Who owns TRANSCODE THERAPEUTICS INC?
- CUSIP Number: 89357l204
Tip: Access positions for across all investors
Analyze quarterly positions in Transcode Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Transcode Therapeutics stock
Who bought or sold TRANSCODE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 282k | $47k | 100% | Dec 2023 |
|
| Private Capital Management | 81k | $13k | 100% | Dec 2023 |
|
| Hrt Financial | 35k | $5.0k | 114% | Dec 2023 |
|
| UBS Group | 7.9k | $1.3k | -95% | Dec 2023 |
|
| Bank of America Corporation | 1.6k | $266.006100 | 100% | Dec 2023 |
|
| Wells Fargo & Company | 155.00 | $25.993500 | 1309% | Dec 2023 |
|
| Royal Bank of Canada | 22.00 | $0 | 0% | Dec 2023 |
|
Who sold out of Transcode Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tang Capital Management | Sep 2023 | 84k | $42k |
| Virtu Financial | Sep 2023 | 31k | $16k |
| Two Sigma Investments | Sep 2023 | 16k | $8.1k |
| Warberg Asset Management | Sep 2023 | 10k | $5.0k |